Sanofi U.S. Revenue and Competitors
Estimated Revenue & Valuation
- Sanofi U.S.'s estimated annual revenue is currently $38.5B per year.
- Sanofi U.S.'s estimated revenue per employee is $371,353
- Sanofi U.S.'s current valuation is $130.4B. (January 2022)
Employee Data
- Sanofi U.S. has 103675 Employees.
- Sanofi U.S. grew their employee count by 2% last year.
Sanofi U.S.'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | Consultant Product Owner | Reveal Email/Phone |
2 | CEO / President | Reveal Email/Phone |
3 | Partner and CEO 3DC at Deerfield Management | Reveal Email/Phone |
4 | Microsoft 365 Apps Owner | Reveal Email/Phone |
5 | Data Product Owner - Supply Chain | Reveal Email/Phone |
6 | CEO Office Project Manager | Reveal Email/Phone |
7 | Global Payroll Process Owner | Reveal Email/Phone |
8 | Chief Key Account Manager | Reveal Email/Phone |
9 | Chief Financial Officer | Reveal Email/Phone |
10 | Chief Medical Officer | Reveal Email/Phone |
Sanofi U.S. Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 27 | 29% | N/A | N/A |
#2 | $35.8M | 156 | 6% | N/A | N/A |
#3 | $5.4M | 27 | 23% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 72 | 50% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 45 | 15% | N/A | N/A |
#8 | $10.3M | 63 | 34% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Sanofi U.S.?
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
keywords:N/A
N/A
Total Funding
103675
Number of Employees
$38.5B
Revenue (est)
2%
Employee Growth %
$130.4B
Valuation
N/A
Accelerator
Sanofi U.S. News
U.S. futures gained after stocks ended little changed on Monday. The Singapore-traded SGX Nifty, an early barometer of India's benchmark Nifty 50, rose 0.12% to...
Amgen sued Sanofi and Regeneron in 2014 after they sought regulatory approval for their rival drug Praluent. The U.S. Food and Drug...
Before joining Sanofi, he has been associated with top players like Pfizer, LVMH, Heineken, and Procter & Gamble in the USA and Brazil. Sanofi...
November 22, 202112:09 PM UTCLast Updated ago Healthcare & PharmaceuticalsBaidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development Reuters 2 minute read 1/2 People walk near a Baidu logo at the company headquarters in Beijing, China April 23, 2021. REUTERS/ ...
Media Update Sanofi announces results of CHMP re-examination of the New Active Substance status for avalglucosidase alfa, a potential new standard of care for the treatment of Pompe disease NOVEMBER 12, 2021 The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use ...